Tohoku J. Exp. Med., 2021 March, 253(3)

Invited Review for the 100th Anniversary of the TJEM

Mass Spectrometry-Based Steroid Profiling: Meeting Unmet Clinical Needs

Man Ho Choi1

1Molecular Recognition Research Center, Korea Institute of Science and Technology, Seoul, Republic of Korea

Despite ongoing concerns regarding its clinical application, mass spectrometry (MS)-based steroid assay represents a promising tool in endocrine research. Recent studies indicate that monitoring the blood levels of individual sterols provides improved diagnostic insight into hyperlipidemia compared with immunoassays routinely used in clinical practice. Hypercortisolism and hyperaldosteronism can also be easily evaluated along with successful subtyping of adrenal diseases using MS-based methods, while metabolic signatures of sex steroids provide experimental evidence of abnormal puberty and male infertility. Many MS-based biological and clinical studies are based on liquid chromatography-mass spectrometry (LC-MS) coupled to electrospray ionization and tandem MS scan modes. However, gas chromatography-mass spectrometry (GC-MS) provides better chromatographic separation. Improved chromatographic resolution enables large-scale steroid profiling to allow a bird-eye view and increase the chances of identifying potent biomarkers in endocrine research. In addition to the technical advantages of MS-based assays over immunoassays, minimizing the sample amounts with acceptable analytical sensitivity and standardization of surrogate materials provides cutting-edge tools for precision and personalized medicine.

Keywords —— adrenal gland; cholesterol; clinical application; mass spectrometry; steroids


Tohoku J. Exp. Med 2021 253, 171-180.

Correspondence: Man Ho Choi, Ph.D., Molecular Recognition Research Center, Korea Institute of Science and Technology (KIST), 5 Hwarang-ro 14-gil, Seongbuk-gu, Seoul 02792, Republic of Korea.